OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Regulation of immunity during visceral Leishmania infection
Vasco Rodrigues, Anabela Cordeiro‐da‐Silva, Mireille Laforge, et al.
Parasites & Vectors (2016) Vol. 9, Iss. 1
Open Access | Times Cited: 236

Showing 1-25 of 236 citing articles:

Climate change influences on the potential geographic distribution of the disease vector tick Ixodes ricinus
Abdelghafar Alkishe, A. Townsend Peterson, Abdallah M Samy
PLoS ONE (2017) Vol. 12, Iss. 12, pp. e0189092-e0189092
Open Access | Times Cited: 152

Global genome diversity of the Leishmania donovani complex
Susanne U. Franssen, Caroline Durrant, Olivia Stark, et al.
eLife (2020) Vol. 9
Open Access | Times Cited: 110

Applications of Nanomaterials in Leishmaniasis: A Focus on Recent Advances and Challenges
Kiran Saleem, Zainab Khursheed, Christophe Hano, et al.
Nanomaterials (2019) Vol. 9, Iss. 12, pp. 1749-1749
Open Access | Times Cited: 94

Role of Cytokines in Experimental and Human Visceral Leishmaniasis
Mukesh Samant, Utkarsha Sahu, Satish Chandra Pandey, et al.
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 75

Leishmaniasis in the United States: Emerging Issues in a Region of Low Endemicity
John M Curtin, Naomi Aronson
Microorganisms (2021) Vol. 9, Iss. 3, pp. 578-578
Open Access | Times Cited: 64

Antileishmanial Drug Discovery and Development: Time to Reset the Model?
Ana Isabel Olías-Molero, Concepción de la Fuente, Montserrat Cuquerella, et al.
Microorganisms (2021) Vol. 9, Iss. 12, pp. 2500-2500
Open Access | Times Cited: 56

Immunoinformatics-aided design of a potential multi-epitope peptide vaccine against Leishmania infantum
Bahareh Vakili, Mahboobeh Eslami, Gholamreza Hatam, et al.
International Journal of Biological Macromolecules (2018) Vol. 120, pp. 1127-1139
Closed Access | Times Cited: 74

Ubc13: the Lys63 ubiquitin chain building machine
Curtis D. Hodge, Leo Spyracopoulos, J. N. Mark Glover
Oncotarget (2016) Vol. 7, Iss. 39, pp. 64471-64504
Open Access | Times Cited: 73

Virus-like Particle Display of the α-Gal Carbohydrate for Vaccination against Leishmania Infection
Anna Paula V. Moura, Luiza C. B. Santos, Carlos Ramon Nascimento Brito, et al.
ACS Central Science (2017) Vol. 3, Iss. 9, pp. 1026-1031
Open Access | Times Cited: 73

Revisiting the Mechanisms of Immune Evasion Employed by Human Parasites
Monrat Chulanetra, Wanpen Chaicumpa
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 55

From infection to vaccination: reviewing the global burden, history of vaccine development, and recurring challenges in global leishmaniasis protection
Greta Volpedo, Ryan H. Huston, Erin A. Holcomb, et al.
Expert Review of Vaccines (2021) Vol. 20, Iss. 11, pp. 1431-1446
Open Access | Times Cited: 47

Larval habitat diversity and Anopheles mosquito species distribution in different ecological zones in Ghana
Isaac Amankona Hinne, Simon K. Attah, Benedicta Ayiedu Mensah, et al.
Parasites & Vectors (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 44

Uptake pathways of cell-penetrating peptides in the context of drug delivery, gene therapy, and vaccine development
Moataz Dowaidar
Cellular Signalling (2024) Vol. 117, pp. 111116-111116
Closed Access | Times Cited: 8

Arginase and its mechanisms in Leishmania persistence
Gabriela Pessenda, João S. Silva
Parasite Immunology (2020) Vol. 42, Iss. 7
Closed Access | Times Cited: 45

A new multi-epitope peptide vaccine induces immune responses and protection against Leishmania infantum in BALB/c mice
Bahareh Vakili, Navid Nezafat, Bijan Zare, et al.
Medical Microbiology and Immunology (2019) Vol. 209, Iss. 1, pp. 69-79
Closed Access | Times Cited: 44

The Absence of HIF-1α Increases Susceptibility to Leishmania donovani Infection via Activation of BNIP3/mTOR/SREBP-1c Axis
Inês Mesquita, Carolina Ferreira, Diana Moreira, et al.
Cell Reports (2020) Vol. 30, Iss. 12, pp. 4052-4064.e7
Open Access | Times Cited: 40

Immunotherapy in treatment of leishmaniasis
Maryam Akbari, Ahmad Oryan, Gholamreza Hatam
Immunology Letters (2021) Vol. 233, pp. 80-86
Closed Access | Times Cited: 34

In-silico design of an immunoinformatics based multi-epitope vaccine against Leishmania donovani
Subhadip Saha, Shubham Vashishtha, Bishwajit Kundu, et al.
BMC Bioinformatics (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 26

Immunotherapy and immunochemotherapy in combating visceral leishmaniasis
Ganesh Yadagiri, Aakriti Singh, Kanika Arora, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 14

A review of the biology, ecology, and control of the northern fowl mite, Ornithonyssus sylviarum (Acari: Macronyssidae)
Amy C. Murillo, Bradley A. Mullens
Veterinary Parasitology (2017) Vol. 246, pp. 30-37
Closed Access | Times Cited: 46

Mahanine exerts in vitro and in vivo antileishmanial activity by modulation of redox homeostasis
Saptarshi Roy, Devawati Dutta, Eswara Murali Satyavarapu, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 41

Topical treatment of cutaneous leishmaniasis with novel amphotericin B-miltefosine co-incorporated second generation ultra-deformable liposomes
M. Junaid Dar, Sidra Khalid, Craig A. McElroy, et al.
International Journal of Pharmaceutics (2019) Vol. 573, pp. 118900-118900
Closed Access | Times Cited: 37

Page 1 - Next Page

Scroll to top